CI Investments Inc’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
35,358
+30,035
+564% +$1.97M 0.01% 441
2026
Q1
$379K Sell
5,323
-434
-8% -$34.2K ﹤0.01% 515
2025
Q4
$472K Sell
5,757
-2,613
-31% -$204K ﹤0.01% 498
2025
Q3
$629K Sell
8,370
-2,607
-24% -$194K ﹤0.01% 484
2025
Q2
$813K Sell
10,977
-313
-3% -$21.8K ﹤0.01% 456
2025
Q1
$911K Sell
11,290
-3,499
-24% -$301K ﹤0.01% 443
2024
Q4
$1.16M Sell
14,789
-32,881
-69% -$2.79M ﹤0.01% 403
2024
Q3
$4.47M Sell
47,670
-19,355
-29% -$1.62M 0.02% 305
2024
Q2
$5.22M Buy
67,025
+1,464
+2% +$119K 0.02% 275
2024
Q1
$5.96M Buy
65,561
+36,509
+126% +$3.04M 0.02% 286
2023
Q4
$2.25M Buy
29,052
+6,212
+27% +$435K 0.01% 323
2023
Q3
$1.55M Buy
22,840
+14,709
+181% +$1.07M 0.01% 339
2023
Q2
$661K Buy
8,131
+7,172
+748% +$572K ﹤0.01% 409
2023
Q1
$79K Buy
+959
New +$68.5K ﹤0.01% 791

Other funds holding GEHC

CI Investments Inc's GEHC Position: Q2 2026 in Review

CI Investments Inc increased its GE HealthCare (GEHC) stake by 564% in Q2 2026, buying an estimated $1.97M and bringing the position to 35,358 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #441.

CI Investments Inc first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.96M in Q1 2024. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • CI Investments Inc held 35,358 shares of GE HealthCare worth $2.26M as of Q2 2026.
  • CI Investments Inc bought 30,035 GE HealthCare shares in Q2 2026, an estimated $1.97M.
  • GE HealthCare made up 0.01% of CI Investments Inc's portfolio in Q2 2026, its #441 holding.
  • CI Investments Inc first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • CI Investments Inc's GE HealthCare position peaked at $5.96M in Q1 2024.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.